Anoctamin-2 is Encephalitogenic and is a Target of EBNA1 Adaptive Immune Responses in Multiple SclerosisShow others and affiliations
2024 (English)In: Multiple Sclerosis Journal, ISSN 1352-4585, E-ISSN 1477-0970, Vol. 30, no 3, p. 8-9Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Sage Publications , 2024. Vol. 30, no 3, p. 8-9
National Category
Neurology
Identifiers
URN: urn:nbn:se:kth:diva-357803ISI: 001324906900007OAI: oai:DiVA.org:kth-357803DiVA, id: diva2:1924647
Note
QC 20250107
2025-01-072025-01-072025-01-17Bibliographically approved